A Guardian Book of the Week Longlisted for the PEN / E. O. Wilson Literary Science Writing Award
An award-winning physician and scientist makes the game-changing case that genetic females are stronger than males at every stage of life
Here are some facts: Women live longer than men. They have stronger immune systems. They're better at fighting cancer and surviving famine, and even see the world in a wider variety of colors. They are simply stronger than men at every stage of life. Why is this? And why are we taught the opposite?
To find out, Dr. Sharon Moalem drew on his own medical experiences - treating premature babies in the neonatal intensive care unit; recruiting the elderly for neurogenetic studies; tending to HIV-positive orphans in Thailand - and tried to understand why in every instance men were consistently less likely to thrive. The answer, he discovered, lies in our genetics: two X chromosomes offer a powerful survival advantage.
With clear, captivating prose that weaves together eye-opening research, case studies, diverse examples ranging from the behavior of honeybees to American pioneers, as well as experiences from his personal life and his own patients, Moalem explains why genetic females triumph over males when it comes to resiliency, intellect, stamina, immunity and much more. He also calls for a reconsideration of our male-centric, one-size-fits-all view of medical studies and even how we prescribe medications - a view that still sees women through the lens of men.
Revolutionary and yet utterly convincing, The Better Half will make you see humanity and the survival of our species anew.
Sharon Moalem, MD, PhD, is an award-winning physician-scientist and geneticist. He is the author of the New York Times bestseller Survival of the Sickest and Inheritance, an Amazon Best Science Book of the Year, among other books. His work brings together evolution, genetics, and medicine to revolutionize how we understand and treat disease, and his clinical research led to the discovery of two new rare genetic conditions, and to his discovery of a first-in-class antibiotic which targets ‘superbug’ infections. His books have been translated into more than 35 languages.